These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 38042464)
1. Targets, trials and tribulations in Alzheimer therapeutics. Gharat R; Dixit G; Khambete M; Prabhu A Eur J Pharmacol; 2024 Jan; 962():176230. PubMed ID: 38042464 [TBL] [Abstract][Full Text] [Related]
2. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
3. Cognitive symptoms of Alzheimer's disease: clinical management and prevention. Joe E; Ringman JM BMJ; 2019 Dec; 367():l6217. PubMed ID: 31810978 [TBL] [Abstract][Full Text] [Related]
4. Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease. Ruthirakuhan M; Herrmann N; Suridjan I; Abraham EH; Farber I; Lanctôt KL Expert Opin Pharmacother; 2016 Dec; 17(18):2417-2429. PubMed ID: 27825018 [TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease (AD) therapeutics - 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality. Mullane K; Williams M Biochem Pharmacol; 2018 Dec; 158():359-375. PubMed ID: 30273553 [TBL] [Abstract][Full Text] [Related]
6. Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents. Lahiri DK; Rogers JT; Greig NH; Sambamurti K Curr Pharm Des; 2004; 10(25):3111-9. PubMed ID: 15544501 [TBL] [Abstract][Full Text] [Related]
13. Current druggable targets for therapeutic control of Alzheimer's disease. Gupta GL; Samant NP Contemp Clin Trials; 2021 Oct; 109():106549. PubMed ID: 34464763 [TBL] [Abstract][Full Text] [Related]
14. Tea polyphenols as multi-target therapeutics for Alzheimer's disease: An in silico study. Mazumder MK; Choudhury S Med Hypotheses; 2019 Apr; 125():94-99. PubMed ID: 30902161 [TBL] [Abstract][Full Text] [Related]
15. Current and emerging therapies for Alzheimer's disease. Nygaard HB Clin Ther; 2013 Oct; 35(10):1480-9. PubMed ID: 24139420 [TBL] [Abstract][Full Text] [Related]
16. Preclinical Models of Alzheimer's Disease: Relevance and Translational Validity. Mullane K; Williams M Curr Protoc Pharmacol; 2019 Mar; 84(1):e57. PubMed ID: 30802363 [TBL] [Abstract][Full Text] [Related]